Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Plant Biotechnology (Tokyo, Japan)
|
January 12, 2024
Molecular characterization of Satsuma mandarin (<i>Citrus unshiu</i> Marc.) VASCULAR PLANT ONE-ZINC FINGER2 (CuVOZ2) interacting with CuFT1 and CuFT3
Nazmul Hasan, Naoki Tokuhara, Takayuki Noda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Miki Murota, Roberta Tufi, Naoki Tokuhara, et al.
Current Pharmaceutical Biotechnology
|
February 10, 2009
The utilization of gene targeting models during in preclinical study of drug discovery process--example of phenotypic and functional analysis of Cacna1beta gene product
Norimasa Miyamoto, Kana Namiki, Naoki Tokuhara, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2004
Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice
Toshihiko Yamauchi, Akira Ishibashi, Kohdoh Shikata, et al.
Epilepsia
|
June 4, 2011
Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara, et al.
Journal of Receptor and Signal Transduction Research
|
July 7, 2007
Involvement of p38alpha in kainate-induced seizure and neuronal cell damage
Kana Namiki, Akira Nakamura, Mitsuko Furuya, et al.
The Journal of Biological Chemistry
|
August 20, 2010
N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis
Naoki Tokuhara, Kana Namiki, Mai Uesugi, et al.
The Journal of Biological Chemistry
|
May 29, 2012
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis
Kana Namiki, Hirofumi Matsunaga, Kento Yoshioka, et al.
Acta Neuropathologica Communications
|
February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Plant Biotechnology (Tokyo, Japan)
|
January 12, 2024
Molecular characterization of Satsuma mandarin (<i>Citrus unshiu</i> Marc.) VASCULAR PLANT ONE-ZINC FINGER2 (CuVOZ2) interacting with CuFT1 and CuFT3
Nazmul Hasan, Naoki Tokuhara, Takayuki Noda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Miki Murota, Roberta Tufi, Naoki Tokuhara, et al.
Current Pharmaceutical Biotechnology
|
February 10, 2009
The utilization of gene targeting models during in preclinical study of drug discovery process--example of phenotypic and functional analysis of Cacna1beta gene product
Norimasa Miyamoto, Kana Namiki, Naoki Tokuhara, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 24, 2004
Effect of E6060 [4-{5-[7-fluoro-4-(trifluoromethyl)benzo[b]furan-2-yl]-1H-2-pyrrolyl}benzoic acid], a novel subtype-selective retinoid, on lupus-like nephritis in female (NZBxNZW)F1 mice
Toshihiko Yamauchi, Akira Ishibashi, Kohdoh Shikata, et al.
Epilepsia
|
June 4, 2011
Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy
Takahisa Hanada, Yutaka Hashizume, Naoki Tokuhara, et al.
Journal of Receptor and Signal Transduction Research
|
July 7, 2007
Involvement of p38alpha in kainate-induced seizure and neuronal cell damage
Kana Namiki, Akira Nakamura, Mitsuko Furuya, et al.
The Journal of Biological Chemistry
|
August 20, 2010
N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis
Naoki Tokuhara, Kana Namiki, Mai Uesugi, et al.
The Journal of Biological Chemistry
|
May 29, 2012
Mechanism for p38α-mediated experimental autoimmune encephalomyelitis
Kana Namiki, Hirofumi Matsunaga, Kento Yoshioka, et al.
Acta Neuropathologica Communications
|
February 6, 2020
Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease
Malcolm Roberts, Ioanna Sevastou, Yoichi Imaizumi, et al.
Page
of 1